Email
Print
Dentists confront challenging situations in controlling hemorrhage during deep cavity preparation and before impressions or cementation of restorations. In order to ensure best bond and least contamination dentist must be familiar with the hemostatic agents available in the market and to be able to choose the appropriate one for specific situation. To achieve healthier outcomes during taking impression or using bonding agents, common hemostatic agents recommended before or during etching, are supposed to be rinsed off properly. It is also suggested to use these agents with etch-and-rinse adhesive systems.
Many novel hemostats and tissue sealants are being developed to address trauma-associated hemorrhages and contaminations associated with sealants. For example, Novartis's Recombumin is a recombinant albumin derived from humans, which has the potential to seal leakages of fluids or gases from surgical incision sites. It is non-toxic and is highly cost-effective compared with animal-derived sealants. The launch of such products will have a significant impact in the market, and propel the demand for innovative products in five years. Vascular Solutions and Baxter International Incorporation have introduced three new products in the market in recently to ensure improved performance of the products and enhance the quality leading to market growth.
Companies engaged in hemostatic agents market are focused majorly on acquisitions. Baxter International Incorporation, Mallinckrodt Plc, C.R. Brad Incorporation, Integra Life Sciences Corporation are a few companies involved in acquisition as part of their growth strategies. The acquisitions are meant to improve product portfolio, solve existing issues with the hemostatic agents and to enhance the market share geographically. The global hemostatic agents market is estimated to reach revenue of $8,347.9m by 2022 with 7.1% CAGR. Americas region is projected to maintain its dominance in the market however Asia-Pacific region is forecast to witness fastest growth during 2017-2022.
Browse Related Reports:
- Hemodynamic Monitoring Systems Market: By Type (Minimally Invasive, Non-invasive, Invasive); Product (Pulmonary, Cardiac, Disposables) -Forecast (2016-2021)
- Blood Culture Tests Market: By Type ( Gram-Positive, Gram-Negative, Yeast); By Products ( Consumables, Instruments, Software, Media); By Application (Bacteremia, Fungemia); By End Users- With Forecast (2017 - 2022)
About IndustryARC:
IndustryARC is a research and consulting firm that publishes more than 500 reports annually in various industries, such as Agriculture, Automotive, Automation & Instrumentation, Chemicals and Materials, Energy and Power, Electronics, Food & Beverages, Information Technology, Life sciences & Healthcare.
IndustryARC primarily focuses on Cutting Edge Technologies and Newer Applications of the Market. Our Custom Research Services are designed to provide insights on the constant flux in the global demand-supply gap of markets. Our strong analyst team enables us to meet the client research needs at a very quick speed with a variety of options for your business.
We look forward to support the client to be able to better address customer needs; stay ahead in the market; become the top competitor and get real-time recommendations on business strategies and deals. Contact us to find out how we can help you today.
Contact Us:
Mr. Venkateshwar Reddy
Business Development Manager
Email: [email protected]
Contact Sales: 1-614-588-8538 (Ext-101)
Connect with us on LinkedIn - https://www.linkedin.com/company/industryarc